UNSPSC 51442439: Sodium iopodate

This classification denotes a diagnostic reagent with the molecular formula C12H12I3N2O2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) F316LLW9WW, chemically known as 2,4,6-triiodo-3-((dimethylaminomethylene)amino)hydrocinnamic acid but more generally known as ipodate sodium, which bears U.S. National Institutes of Health Compound Identifier 5241. European Medicines Agency schedules Sodium iopodate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12441MIG.

UNSPSC 51442439 Sodium iopodate, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The two recent opportunities posted under this code are unrelated to sodium iopodate — one concerns maintenance services for Rapiscan X-ray inspection systems, the other addresses copper sulfate supply. Neither opportunity involves the contrast agents, imaging pharmaceuticals, or medical diagnostic compounds the code is intended to cover. The mismatch suggests either misclassification at posting or a data artifact rather than substantive procurement volume under the code.

Broward County Aviation Department issued an RFI (BLD2132311F1) on June 25, 2026, with responses due July 28, 2026, to contest or affirm a proposed sole-source designation for Rapiscan X-ray system maintenance services; Pasco County, Florida posted an RFQ (RFQFP261004) on June 3, 2026, with proposals due June 26, 2026, for large copper sulfate crystals and liquid copper sulfate on an as-needed basis. Neither opportunity reflects procurement of products or services within the sodium iopodate category. State and local procurement activity under this code does not currently support a reliable signal for business development targeting.